Pharmacist Moms Group

Videos
View More
“We’ve Got to Get This Right From the Start”: Expert Discusses MDPNP Impacts on Pharmacies

Ronna Hauser, PharmD, senior vice president of policy and pharmacy affairs at NCPA, discussed concerns the association has with the implementation of the Medicare Drug Price Negotiation Plan

The Power of Knowledge: Patient Education Is a Tool in Preventing C difficile Recurrence
The Pediatric C difficile Surge and What Pharmacists Can Do
Unseen Threats: The Hospital Environment’s Role in C difficile Colonization
NCPA Report Outlines Potential Negative Impacts of MDPNP, Solutions

Ronna Hauser, PharmD, senior vice president of policy and pharmacy affairs at NCPA, discusses concerns about the implementation of the MDPNP.

AAN 2025: Pharmacists Play Critical Role in Monitoring, Managing Lecanemab Therapy

Philip Kuball, MD, neurology resident at NYU Langone Health, highlights the integral role of pharmacists in monitoring patient eligibility, managing dosing schedules, and ensuring safe medication interactions for lecanemab treatment in Alzheimer disease.

AAN 2025: Insights on Pediatric Multiple Sclerosis Treatment and Management

Lauren B. Krupp, MD, FAAN, provides comprehensive guidance on treating pediatric multiple sclerosis, emphasizing early intervention, high-efficacy therapies, and holistic family support.

First-Line Focus: Molecular Testing and Guideline-Directed Therapy in EGFR-Positive NSCLC

A panelist discusses how waiting for molecular testing results before initiating treatment for non–small cell lung cancer (NSCLC) is crucial because patients with EGFR mutations can avoid chemotherapy and immunotherapy in favor of targeted oral agents like osimertinib, which offer survival benefits with minimal toxicity compared to traditional treatments, while premature immunotherapy could cause severe immune-related adverse events that might preclude later use of more appropriate targeted therapies.

Overcoming Challenges in NSCLC Management From a Pharmacist’s Perspective

A panelist discusses how non–small cell lung cancer presents significant treatment challenges due to its prevalence, high mortality rate, poor 5-year survival outcomes, and the difficulty of managing patients with advanced disease who often have poor performance status and multiple metastases, emphasizing the importance of pharmacist involvement for proper dosing, growth factor support, and comprehensive patient education about chemotherapy.

Official Media Partner

Official Media Partner

Official CE Partner

Official CE Partner

Founder of Women Pharmacist Day

Founder of Women Pharmacist Day
pharmacist moms group logo
Stay In Touch
an mjh life sciences brand

© 2021 MJH Life Sciences and Pharmacy Times®. All rights reserved.

Privacy Policy